Retatrutide Research: FDA Status, Structure and Receptor Pharmacology
Retatrutide, known in the literature by its development code LY3437943, is Eli Lilly's investigational triple agonist: a single peptide that activates the GIP…
Shop by research area
Most requested
Guides & help
5.0 from 25 customer reviewssupport@exolabz.coReplies in about an hour
Shop by research area All 44 compounds →
Most requested
Start here
Research libraryMethods, analytics and lab practice articlesResearch peptides in the USASourcing, testing and delivery explainedChoosing a supplierWhat to check before you orderPeptide glossaryTerms from HPLC to lyophilisationHelp centre
Your account
Programs